HCG · Healthcare · Medical Care Facilities
Composite scorecard: 24/100 — Quality 22 · Valuation 1 · Momentum 66
| Share price | ₹653.70 |
| Market cap | ₹9,950 Cr |
| P/B ratio | 7.2 |
| ROE | 9.2% |
| ROCE | 7.0% |
| Book value | ₹92.07 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹2,545 Cr | ₹23 Cr | 18.0% |
| 2025 | ₹2,218 Cr | ₹49 Cr | 17.0% |
| 2024 | ₹1,908 Cr | ₹41 Cr | 17.0% |
| 2023 | ₹1,691 Cr | ₹18 Cr | 18.0% |
| 2022 | ₹1,395 Cr | ₹39 Cr | 17.0% |
HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncology, radiation and surgical oncology, molecular imaging and theranostics, chemotherapy, robotic surgery, actinium and lutetium therapy, immunotherapy, psycho-oncology, targeted drug therapy, bone marro